In this issue, we present another installment of our quarterly review of dealmaking—for January-March 2004. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
Some notes about our coverage: we limit our review to human health care (thus no animal health or agricultural transactions) alliances, mergers and acquisitions (where a definitive agreement has been...